Mitochondrial nanomedicine: Subcellular organelle-specific delivery of molecular medicines

Mitchell, 2020, The mitochondria-targeted peptide SS-31 binds lipid bilayers and modulates surface electrostatics as a key component of its mechanism of action, J Biol Chem, 295, 7452, 10.1074/jbc.RA119.012094 Weissig, 1998, DQAsomes: a novel potential drug and gene delivery system made from dequalinium, Pharm Res, 15, 334, 10.1023/A:1011991307631 Szeto, 2006, Cell-permeable, mitochondrial-targeted, peptide antioxidants, AAPS J, 8, E277, 10.1007/BF02854898 DiMauro, 2017 Milane, 2015, Mitochondrial biology, targets, and drug delivery, J Control Release, 207, 40, 10.1016/j.jconrel.2015.03.036 Milane, 2021, Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine, Drug Deliv Transl Res, 10.1007/s13346-021-00911-y Carl Zimmer, J. C. a. S.-L. W. Coronavirus vaccine tracker, <https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html> (. Zinovkin, 2019, Mitochondria-targeted drugs, Curr Mol Pharmacol, 12, 202, 10.2174/1874467212666181127151059 Tan, 2021, Mitochondria: The metabolic switch of cellular oncogenic transformation, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 10.1016/j.bbcan.2021.188534 Son, 2021, Aging: all roads lead to mitochondria, Seminars in Cell & Developmental Biology, 10.1016/j.semcdb.2021.02.006 Dymkowska, 2021, The involvement of autophagy in the maintenance of endothelial homeostasis: The role of mitochondria, Mitochondrion, 57, 131, 10.1016/j.mito.2020.12.013 Schultz, 2003, Apoptosis: programmed cell death at a molecular level, Seminars in Arthritis and Rheumatism, 32, 345, 10.1053/sarh.2003.50005 Wang, 2020, Endolysosomal targeting of mitochondria is integral to BAX-mediated mitochondrial permeabilization during apoptosis signaling, Developmental Cell, 53, 627, 10.1016/j.devcel.2020.05.014 Mishra, 2016, Metabolic regulation of mitochondrial dynamics, J Cell Biol, 212, 379, 10.1083/jcb.201511036 Wang, 2009, The role of mitochondria in apoptosis, Annu Rev Genet, 43, 95, 10.1146/annurev-genet-102108-134850 Fadeel, 2008, Big wheel keeps on turning: apoptosome regulation and its role in chemoresistance, Cell Death & Differentiation, 15, 443, 10.1038/sj.cdd.4402265 Bloemberg, 2019, Autophagy, apoptosis, and mitochondria: molecular integration and physiological relevance in skeletal muscle, Am J Physiol Cell Physiol, 317, C111, 10.1152/ajpcell.00261.2018 Genovese, 2020, Mitochondria as the decision makers for cancer cell fate: from signaling pathways to therapeutic strategies, Cell Calcium, 92, 10.1016/j.ceca.2020.102308 Favaloro, 2012, Role of apoptosis in disease, Aging, 4, 330, 10.18632/aging.100459 Briston, 2017, Mitochondrial permeability transition pore: sensitivity to opening and mechanistic dependence on substrate availability, Sci Rep, 7, 10492, 10.1038/s41598-017-10673-8 Hüttemann, 2007, Regulation of mitochondrial oxidative phosphorylation through cell signaling, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1773, 1701, 10.1016/j.bbamcr.2007.10.001 Bonora, 2014, The mitochondrial permeability transition pore and cancer: molecular mechanisms involved in cell death, Frontiers in Oncology, 4, 10.3389/fonc.2014.00302 López-Lázaro, 2008, The Warburg effect: why and how do cancer cells activate glycolysis in the presence of oxygen?, Anticancer Agents Med Chem, 8, 305, 10.2174/187152008783961932 Mathupala, 2006, Hexokinase II: cancer’s double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria, Oncogene, 25, 4777, 10.1038/sj.onc.1209603 Pedersen, 2007, Warburg, me and hexokinase 2: multiple discoveries of key molecular events underlying one of cancers’ most common phenotypes, the “Warburg effect”, i.e., elevated glycolysis in the presence of oxygen, J Bioenerg Biomembr, 39, 211, 10.1007/s10863-007-9094-x Dan Dunn, 2015, Reactive oxygen species and mitochondria: a nexus of cellular homeostasis, Redox Biol, 6, 472, 10.1016/j.redox.2015.09.005 Quinlan, 2014, The 2-oxoacid dehydrogenase complexes in mitochondria can produce superoxide/hydrogen peroxide at much higher rates than complex I, J Biol Chem, 289, 8312, 10.1074/jbc.M113.545301 Abate, 2020, Mitochondria as playmakers of apoptosis, autophagy and senescence, Seminars in Cell & Developmental Biology, 98, 139, 10.1016/j.semcdb.2019.05.022 Ferro, 2020, Autophagy and mitophagy in cancer metabolic remodelling, Seminars in Cell & Developmental Biology, 98, 129, 10.1016/j.semcdb.2019.05.029 Zhang, 2009, Role of BNIP3 and NIX in cell death, autophagy, and mitophagy, Cell Death & Differentiation, 16, 939, 10.1038/cdd.2009.16 Whitworth, 2017, PINK1/Parkin mitophagy and neurodegeneration—what do we really know in vivo?, Current Opinion in Genetics & Development, 44, 47, 10.1016/j.gde.2017.01.016 Matsuda, 2010, PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy, J Cell Biol, 189, 211, 10.1083/jcb.200910140 Chan, 2011, Broad activation of the ubiquitin–proteasome system by Parkin is critical for mitophagy, Hum Mol Genet, 20, 1726, 10.1093/hmg/ddr048 Pickrell, 2015, The roles of PINK1, Parkin, and mitochondrial fidelity in Parkinson’s disease, Neuron, 85, 257, 10.1016/j.neuron.2014.12.007 Hoshino, 2013, Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart, Nat Commun, 4, 2308, 10.1038/ncomms3308 Cole, 2016, evolution of per-cell organelle number, Front Cell Dev Biol, 4, 85, 10.3389/fcell.2016.00085 Wisnovsky, 2016, Mitochondrial DNA repair and replication proteins revealed by targeted chemical probes, Nat Chem Biol, 12, 567, 10.1038/nchembio.2102 Craven, 2017, Recent advances in mitochondrial disease, Annu Rev Genomics Hum Genet, 18, 257, 10.1146/annurev-genom-091416-035426 Paupe, V. & Prudent, J. New insights into the role of mitochondrial calcium homeostasis in cell migration. doi:10.17863/CAM.12394 (2017). Grandemange, 2009, Mitochondrial dynamics and cancer, Seminars in Cancer Biology, 19, 50, 10.1016/j.semcancer.2008.12.001 Maycotte, P. et al. Mitochondrial dynamics and cancer. Tumor Biology 39, 1010428317698391, doi:https://doi.org/10.1177/1010428317698391 (2017). Franco, 2016, Correcting mitochondrial fusion by manipulating mitofusin conformations, Nature, 540, 74, 10.1038/nature20156 Landes, 2011, Mitochondrial outer membrane permeabilization during apoptosis: the role of mitochondrial fission, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1813, 540, 10.1016/j.bbamcr.2011.01.021 Renault, 2015, Mitochondrial shape governs BAX-induced membrane permeabilization and apoptosis, Molecular Cell, 57, 69, 10.1016/j.molcel.2014.10.028 Scorrano, 2013, Keeping mitochondria in shape: a matter of life and death, Eur J Clin Invest, 43, 886, 10.1111/eci.12135 Yao, 2019, Mitochondrial fusion supports increased oxidative phosphorylation during cell proliferation, eLife, 8, 10.7554/eLife.41351 Gao, 2015, Targeted cancer therapy; nanotechnology approaches for overcoming drug resistance, Curr Med Chem, 22, 1335, 10.2174/0929867322666150209151851 Susa, 2011, Nanoparticles: a promising modality in the treatment of sarcomas, Pharm Res, 28, 260, 10.1007/s11095-010-0173-z Ikeda, 2016, Nanoparticle-mediated targeting of cyclosporine a enhances cardioprotection against ischemia-reperfusion injury through inhibition of mitochondrial permeability transition pore opening, Sci Rep, 6, 20467, 10.1038/srep20467 Tran, 2017, Cancer nanomedicine: a review of recent success in drug delivery, Clin Transl Med, 6, 44, 10.1186/s40169-017-0175-0 Baetke, 2015, Applications of nanoparticles for diagnosis and therapy of cancer, Br J Radiol, 88, 20150207, 10.1259/bjr.20150207 Horobin, 2007, Mitochondriotropics: a review of their mode of action, and their applications for drug and DNA delivery to mammalian mitochondria, Journal of Controlled Release, 121, 125, 10.1016/j.jconrel.2007.05.040 Zhou, 2019, Mitochondria-targeting nanomedicine: an effective and potent strategy against aminoglycosides-induced ototoxicity, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 126, 59, 10.1016/j.ejps.2018.04.027 Ferreira, 2018, Scavenging of reactive oxygen and nitrogen species with nanomaterials, Nano Res, 11, 4955, 10.1007/s12274-018-2092-y Zielonka, 2017, Mitochondria-targeted triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applications, Chem Rev, 117, 10043, 10.1021/acs.chemrev.7b00042 Horton, 2008, Mitochondria-penetrating peptides, Chem Biol, 15, 375, 10.1016/j.chembiol.2008.03.015 Shi, 2018, Mitochondria-targeted delivery of doxorubicin to enhance antitumor activity with HER-2 peptide-mediated multifunctional pH-sensitive DQAsomes, Int J Nanomedicine, 13, 4209, 10.2147/IJN.S163858 Kurtoglu, 2009, From delocalized lipophilic cations to hypoxia: blocking tumor cell mitochondrial function leads to therapeutic gain with glycolytic inhibitors, Mol Nutr Food Res, 53, 68, 10.1002/mnfr.200700457 Heller, 2012, Targeting drugs to mitochondria, European Journal of Pharmaceutics and Biopharmaceutics, 82, 1, 10.1016/j.ejpb.2012.05.014 Modica-Napolitano, 2001, Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells, Adv Drug Deliv Rev, 49, 63, 10.1016/S0169-409X(01)00125-9 Zhang, 2019, Mitochondria-specific drug release and reactive oxygen species burst induced by polyprodrug nanoreactors can enhance chemotherapy, Nat Commun, 10, 1704, 10.1038/s41467-019-09566-3 Schmidt, 2010, Mitochondrial protein import: from proteomics to functional mechanisms, Nat Rev Mol Cell Biol, 11, 655, 10.1038/nrm2959 Fukasawa, 2015, MitoFates: improved prediction of mitochondrial targeting sequences and their cleavage sites, Molecular &amp;amp; Cellular Proteomics, 14, 1113, 10.1074/mcp.M114.043083 Horton, 2008, Mitochondria-penetrating peptides, Chemistry & Biology, 15, 375, 10.1016/j.chembiol.2008.03.015 Chen, 2013, Dual-targeting pro-apoptotic peptide for programmed cancer cell death via specific mitochondria damage, Sci Rep, 3, 3468, 10.1038/srep03468 Inc., S. B Medicine, U. S. N. L. o Medicine, U. S. N. L. o Chatfield, 2019, Elamipretide improves mitochondrial function in the failing human heart, JACC Basic Transl Sci, 4, 147, 10.1016/j.jacbts.2018.12.005 Owens, 2002, New horizons — alternative routes for insulin therapy, Nat Rev Drug Discov, 1, 529, 10.1038/nrd836 Patel, 2010, Mitochondria-targeted liposomes improve the apoptotic and cytotoxic action of sclareol, J Liposome Res, 20, 244, 10.3109/08982100903347931 Migliore, 2010, Brain delivery of proteins by the intranasal route of administration: a comparison of cationic liposomes versus aqueous solution formulations, J Pharm Sci, 99, 1745, 10.1002/jps.21939 Zheng, 2015, Intranasal H102 peptide-loaded liposomes for brain delivery to treat Alzheimer’s disease, Pharm Res, 32, 3837, 10.1007/s11095-015-1744-9 Weissig, 2015, DQAsomes as the prototype of mitochondria-targeted pharmaceutical nanocarriers: preparation, characterization, and use, Methods in molecular biology (Clifton, N.J.), 1265, 1, 10.1007/978-1-4939-2288-8_1 Shi, 2018, Mitochondria-targeted delivery of doxorubicin to enhance antitumor activity with HER-2 peptide-mediated multifunctional pH-sensitive DQAsomes, Int J Nanomedicine, 13, 4209, 10.2147/IJN.S163858 Vila, 2003, Targeting programmed cell death in neurodegenerative diseases, Nat Rev Neurosci, 4, 365, 10.1038/nrn1100 Johri, 2012, Mitochondrial dysfunction in neurodegenerative diseases, Journal of Pharmacology and Experimental Therapeutics, 342, 619, 10.1124/jpet.112.192138 Benn, 2004, Adult neuron survival strategies — slamming on the brakes, Nat Rev Neurosci, 5, 686, 10.1038/nrn1477 Van Giau, 2018, Mitochondrial therapeutic interventions in Alzheimer’s disease, J Neurol Sci, 395, 62, 10.1016/j.jns.2018.09.033 Devi, 2006, Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer’s disease brain is associated with mitochondrial dysfunction, J Neurosci, 26, 9057, 10.1523/JNEUROSCI.1469-06.2006 Du, 2010, Mitochondrial permeability transition pore in Alzheimer’s disease: cyclophilin D and amyloid beta, Biochim Biophys Acta, 1802, 198, 10.1016/j.bbadis.2009.07.005 Pienaar, 2013, Existing and emerging mitochondrial-targeting therapies for altering Parkinson’s disease severity and progression, Pharmacology & Therapeutics, 137, 1, 10.1016/j.pharmthera.2012.08.010 Sonvico, 2018, Surface-modified nanocarriers for nose-to-brain delivery: from bioadhesion to targeting, Pharmaceutics, 10, 10.3390/pharmaceutics10010034 Chen, Y. & Liu, L. Modern methods for delivery of drugs across the blood–brain barrier. Advanced Drug Delivery Reviews 64, 640–665, doi:https://doi.org/10.1016/j.addr.2011.11.010 (2012). Kwon, 2016, Mitochondria-targeting ceria nanoparticles as antioxidants for Alzheimer’s disease, ACS Nano, 10, 2860, 10.1021/acsnano.5b08045 Marrache, 2012, Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics, Proc Natl Acad Sci, 109, 16288, 10.1073/pnas.1210096109 Vaiserman, 2019, Nanodelivery of natural antioxidants: an anti-aging perspective, Front Bioeng Biotechnol, 7, 447, 10.3389/fbioe.2019.00447 Jang, 2018, The role of mitochondria in aging, J Clin Invest, 128, 3662, 10.1172/JCI120842 NCI NCI Milane, L. in Nanomedicine for inflammatory diseases (ed Mansoor Amiji and Lara Milane) Ch. Chapter 9, 319–331 (CRC Press, 2017). Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 Bor, 2019, Nanomedicines for cancer therapy: current status, challenges and future prospects, Ther Deliv, 10, 113, 10.4155/tde-2018-0062 Milane, 2011, Pharmacokinetics and biodistribution of lonidamine/paclitaxel loaded, EGFR-targeted nanoparticles in an orthotopic animal model of multi-drug resistant breast cancer, Nanomedicine, 7, 435, 10.1016/j.nano.2010.12.009 Milane, 2011, Development of EGFR-targeted polymer blend nanocarriers for combination paclitaxel/lonidamine delivery to treat multi-drug resistance in human breast and ovarian tumor cells, Mol Pharm, 8, 185, 10.1021/mp1002653 Milane, 2011, Role of hypoxia and glycolysis in the development of multi-drug resistance in human tumor cells and the establishment of an orthotopic multi-drug resistant tumor model in nude mice using hypoxic pre-conditioning, Cancer Cell Int, 11, 3, 10.1186/1475-2867-11-3 Milane, 2011, Therapeutic efficacy and safety of paclitaxel/lonidamine loaded EGFR-targeted nanoparticles for the treatment of multi-drug resistant cancer, PLoS One, 6, 10.1371/journal.pone.0024075 Fu, 2020, Precise design strategies of nanomedicine for improving cancer therapeutic efficacy using subcellular targeting, Signal Transduct Target Ther, 5, 262, 10.1038/s41392-020-00342-0 Kianamiri, 2020, Mitochondria-targeted polyamidoamine dendrimer-curcumin construct for hepatocellular cancer treatment, Mol Pharm, 17, 4483, 10.1021/acs.molpharmaceut.0c00566 Wang, 2019, Potential mechanisms of action of curcumin for cancer prevention: focus on cellular signaling pathways and miRNAs, Int J Biol Sci, 15, 1200, 10.7150/ijbs.33710 Wang, 2015, Curcumin inhibits aerobic glycolysis and induces mitochondrial-mediated apoptosis through hexokinase II in human colorectal cancer cells in vitro, Anticancer Drugs, 26, 15, 10.1097/CAD.0000000000000132 Jiang, 2017, Designing nanomedicine for immuno-oncology, Nature Biomedical Engineering, 1, 0029, 10.1038/s41551-017-0029 Milane, 2017 Chen, 2020, Effects of sclareol against small cell lung carcinoma and the related mechanism: in vitro and in vivo studies, Anticancer Research, 40, 4947, 10.21873/anticanres.14498 Perl, 2010, Pathogenic mechanisms in systemic lupus erythematosus, Autoimmunity, 43, 1, 10.3109/08916930903374741 Faas, 1866, Mitochondrial function in immune cells in health and disease, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2020, 165845 Lee, 2016, The pathogenesis of systemic lupus erythematosus - from the viewpoint of oxidative stress and mitochondrial dysfunction, Mitochondrion, 30, 1, 10.1016/j.mito.2016.05.007 Perl, 2013, Oxidative stress in the pathology and treatment of systemic lupus erythematosus, Nat Rev Rheumatol, 9, 674, 10.1038/nrrheum.2013.147 Veiseh, 2015, Managing diabetes with nanomedicine: challenges and opportunities, Nat Rev Drug Discov, 14, 45, 10.1038/nrd4477 Li, 2007, Transport and metabolism of MitoQ10, a mitochondria-targeted antioxidant, in Caco-2 cell monolayers, J Pharm Pharmacol, 59, 503, 10.1211/jpp.59.4.0004 Yen, 2018, Effect of liquid ubiquinol supplementation on glucose, lipids and antioxidant capacity in type 2 diabetes patients: a double-blind, randomised, placebo-controlled trial, Br J Nutr, 120, 57, 10.1017/S0007114518001241 Xiao, 2017, The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1, Redox Biology, 11, 297, 10.1016/j.redox.2016.12.022 Wu, 2019, Liver-targeted Nano-MitoPBN normalizes glucose metabolism by improving mitochondrial redox balance, Biomaterials, 222, 10.1016/j.biomaterials.2019.119457 Nübel, 2006, Respiration under control of uncoupling proteins: clinical perspective, Horm Res Paediatr, 65, 300, 10.1159/000092847 Ishigaki, 2005, Dissipating excess energy stored in the liver is a potential treatment strategy for diabetes associated with obesity, Diabetes, 54, 322, 10.2337/diabetes.54.2.322 Panga, 2019, Mitochondrial dysfunction in rheumatoid arthritis: a comprehensive analysis by integrating gene expression, protein-protein interactions and gene ontology data, PLOS ONE, 14, 10.1371/journal.pone.0224632 Fan, 2020, ROS-responsive berberine polymeric micelles effectively suppressed the inflammation of rheumatoid arthritis by targeting mitochondria, Nano-Micro Letters, 12, 10.1007/s40820-020-0410-x Wu, 2016, Li, P. & Zhou, D. miR-613 suppresses ischemia-reperfusion-induced cardiomyocyte apoptosis by targeting the programmed cell death 10 gene, Biosci Trends, 10, 251, 10.5582/bst.2016.01122 Pala, 2020, Nanoparticle-mediated drug delivery for the treatment of cardiovascular diseases, Int J Nanomedicine, 15, 3741, 10.2147/IJN.S250872 Ishikita, 2016, J Am Heart Assoc, 5, 10.1161/JAHA.116.003872